{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T08:00:38Z","timestamp":1785052838612,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"DOI":"10.1007\/s12149-026-02266-1","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T07:30:04Z","timestamp":1785051004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative Imaging Evaluation of Structural and Densitometric Changes in Major Salivary Glands After 177Lu PSMA Radioligand Therapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-3189","authenticated-orcid":false,"given":"Nihat","family":"K\u00f6yl\u00fcce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9799-6398","authenticated-orcid":false,"given":"Fadime","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"issue":"6","key":"2266_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"2266_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M. vd. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.005.","journal-title":"Eur J Cancer"},{"key":"2266_CR3","doi-asserted-by":"publisher","first-page":"101445","DOI":"10.1016\/j.tranon.2022.101445","volume":"21","author":"S Mahajan","year":"2022","unstructured":"Mahajan S, Grewal RK, Friedman KP, Sch\u00f6der H, Pandit-Taskar N. Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: current concepts in imaging and management. Transl Oncol. 2022;21:101445. https:\/\/doi.org\/10.1016\/j.tranon.2022.101445.","journal-title":"Transl Oncol"},{"issue":"3","key":"2266_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/pros.21241","volume":"71","author":"S Minner","year":"2011","unstructured":"Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A. vd. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. Prostate. 2011;71(3):281\u20138. https:\/\/doi.org\/10.1002\/pros.21241.","journal-title":"Prostate"},{"issue":"6","key":"2266_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","volume":"19","author":"MS Hofman","year":"2018","unstructured":"Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T. vd. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018;19(6):825\u201333. https:\/\/doi.org\/10.1016\/S1470-2045(18)30198-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2266_CR6","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):81\u20135.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2266_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.oooo.2018.01.011","volume":"125","author":"TJW Klein Nulent","year":"2018","unstructured":"Klein Nulent TJW, Valstar MH, de Keizer B, Willems SM, Smit LA, Al-Mamgani A, vd. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET\/CT. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(5):478\u201386. https:\/\/doi.org\/10.1016\/j.oooo.2018.01.011.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"2266_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2967\/jnumed.118.214833","volume":"60","author":"M Kesler","year":"2019","unstructured":"Kesler M, Levine C, Hershkovitz D, Mishani E, Menachem Y, Lerman H. vd. 68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: a prospective pilot study. J Nucl Med. 2019;60(2):185\u201391. https:\/\/doi.org\/10.2967\/jnumed.118.214833.","journal-title":"J Nucl Med"},{"issue":"5","key":"2266_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2967\/jnumed.118.207993","volume":"59","author":"D Ta\u00efeb","year":"2018","unstructured":"Ta\u00efeb D, Foletti JM, Bardi\u00e8s M, Rocchi P, Hicks RJ, Haberkorn U. PSMA-targeted radionuclide therapy and salivary gland toxicity: why does it matter? J Nucl Med. 2018;59(5):747\u20138. https:\/\/doi.org\/10.2967\/jnumed.118.207993.","journal-title":"J Nucl Med"},{"issue":"12","key":"2266_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","volume":"57","author":"C Kratochwil","year":"2016","unstructured":"Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F. vd. 225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med. 2016;57(12):1941\u20134. https:\/\/doi.org\/10.2967\/jnumed.116.178673.","journal-title":"J Nucl Med"},{"issue":"10","key":"2266_CR11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.2967\/jnumed.117.191395","volume":"58","author":"C Kratochwil","year":"2017","unstructured":"Kratochwil C, Bruchertseifer F, Rathke H, Bronzel M, Apostolidis C, Weichert W. vd. Targeted \u03b1-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: dosimetry estimate and empiric dose finding. J Nucl Med. 2017;58(10):1624\u201331. https:\/\/doi.org\/10.2967\/jnumed.117.191395.","journal-title":"J Nucl Med"},{"issue":"5","key":"2266_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00259-016-3609-9","volume":"44","author":"L Scarpa","year":"2017","unstructured":"Scarpa L, Buxbaum S, Kendler D, Fink K, Bektic J, Gruber L. vd. The 68Ga\/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates. Eur J Nucl Med Mol Imaging. 2017;44(5):788\u2013800. https:\/\/doi.org\/10.1007\/s00259-016-3609-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2266_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/pros.21090","volume":"70","author":"P Wolf","year":"2010","unstructured":"Wolf P, Freudenberg N, B\u00fchler P, Alt K, Schultze-Seemann W, Wetterauer U. vd. Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer. Prostate. 2010;70(5):562\u20139. https:\/\/doi.org\/10.1002\/pros.21090.","journal-title":"Prostate"},{"key":"2266_CR14","doi-asserted-by":"publisher","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C. vd. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78(16):4786-9. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"issue":"9","key":"2266_CR15","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2967\/jnumed.118.222307","volume":"60","author":"NJ Rupp","year":"2019","unstructured":"Rupp NJ, Umbricht CA, Pizzuto DA, Lenggenhager D, T\u00f6pfer A, M\u00fcller J. vd. First clinicopathologic evidence of a non\u2013PSMA-related uptake mechanism for 68Ga-PSMA-11 in salivary glands. J Nucl Med. 2019;60(9):1270\u20136. https:\/\/doi.org\/10.2967\/jnumed.118.222307.","journal-title":"J Nucl Med"},{"issue":"1","key":"2266_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ph12010018","volume":"12","author":"R T\u00f6nnesmann","year":"2019","unstructured":"T\u00f6nnesmann R, Meyer PT, Eder M, Baranski AC. [177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography. Pharmaceuticals (Basel). 2019;12(1):18. https:\/\/doi.org\/10.3390\/ph12010018.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"2266_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ijrobp.2004.12.051","volume":"62","author":"AWT Konings","year":"2005","unstructured":"Konings AWT, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005;62(4):1187\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.051.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2266_CR18","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jum.15289","volume":"39","author":"GA Sim\u00f5es Lima","year":"2020","unstructured":"Sim\u00f5es Lima GA, L\u00f3pez RVM, de Freitas RMC, Willegaignon J, Sapienza MT, Chammas MC. vd. Evaluation of parotid salivary gland echo texture by ultrasound examinations and correlation with whole-body scintigraphy after radioiodine therapy in patients with differentiated thyroid carcinoma. J Ultrasound Med. 2020;39(9):1811\u20138. https:\/\/doi.org\/10.1002\/jum.15289.","journal-title":"J Ultrasound Med"},{"issue":"15","key":"2266_CR19","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.3390\/cancers15153878","volume":"15","author":"D Groener","year":"2023","unstructured":"Groener D, Wichert J, Adams M, Mader N, Klimek K, Nguyen Ngoc C, vd. Impact of [177Lu]Lu-PSMA-617 radioligand therapy on reference organ uptake assessed by [68Ga]Ga-PSMA-11-PET\/CT. Cancers (Basel). 2023;15(15):3878. https:\/\/doi.org\/10.3390\/cancers15153878.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2266_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0022034509343143","volume":"88","author":"O Grundmann","year":"2009","unstructured":"Grundmann O, Mitchell GC, Limesand KH. Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res. 2009;88(10):894\u2013903. https:\/\/doi.org\/10.1177\/0022034509343143.","journal-title":"J Dent Res"},{"issue":"1","key":"2266_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/stem.2455","volume":"35","author":"I Lombaert","year":"2017","unstructured":"Lombaert I, Movahednia MM, Adine C, Ferreira JN. Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids. Stem Cells. 2017;35(1):97\u2013105. https:\/\/doi.org\/10.1002\/stem.2455.","journal-title":"Stem Cells"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02266-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T07:30:05Z","timestamp":1785051005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02266-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":21,"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02266-1","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NK and FD declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the principles of the Helsinki Declaration and approved by the local ethics committee of Kayseri City Training and Research Hospital (Decision No: 823).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, the requirement for informed consent was waived.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}